Fingerprint
Dive into the research topics of 'Identification of Patients with Ovarian Cancer Experiencing the Highest Benefit from Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically